Trial Profile
Asenapine for Bipolar Depression
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 12 May 2022
Price :
$35
*
At a glance
- Drugs Asenapine (Primary)
- Indications Bipolar depression
- Focus Therapeutic Use
- 20 Jul 2017 Status changed from recruiting to discontinued as funding ended due to recruitment delays.
- 09 May 2016 Planned End Date changed from 1 Oct 2016 to 1 Oct 2017.
- 09 May 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Jul 2017.